Premium
Clofarabine
Author(s) -
Musto Pellegrino,
Ferrara Felicetto
Publication year - 2008
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.23804
Subject(s) - clofarabine , medicine , myeloid leukemia , chemotherapy , leukemia , oncology , intensive care medicine , cytarabine
Although relapse still represents the most relevant obstacle to achieving a cure in acute myeloid leukemia, it offers an opportunity to investigate new therapeutic strategies, mainly in patients who are expected to gain negligible advantage from conventional salvage chemotherapy. In this setting, clofarabine represents 1 of the most promising drugs.